Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Neurology and Therapy|July 1, 2022
Patient Experience in Early-Stage Parkinson's Disease: Using a Mixed Methods Analysis to Identify Which Concepts Are Cardinal for Clinical Trial Outcome AssessmentThomas Morel, Sophie Cleanthous, John Andrejack, et al.
Journal of Patient-Reported Outcomes|April 20, 2023
Development and early qualitative evidence of two novel patient-reported outcome instruments to assess daily functioning in people with early-stage Parkinson'sThomas Morel, Sophie Cleanthous, John Andrejack, et al.
Circulation|November 20, 2012
Stroke after carotid stenting and endarterectomy in the Carotid Revascularization Endarterectomy versus Stenting Trial (CREST)Michael D Hill, William Brooks, Ariane Mackey, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 28, 2020
Safety and target engagement profile of two oxaloacetate doses in Alzheimer's patientsEric D Vidoni, In-Young Choi, Phil Lee, et al.
The New England Journal of Medicine|February 19, 2016
Long-Term Results of Stenting versus Endarterectomy for Carotid-Artery StenosisThomas G Brott, George Howard, Gary S Roubin, et al.
The New England Journal of Medicine|May 28, 2010
Stenting versus endarterectomy for treatment of carotid-artery stenosisThomas G Brott, Robert W Hobson, George Howard, et al.
Research Square|August 7, 2024
Ubiquitin-Proteasome System in the Different Stages of Dominantly Inherited Alzheimer's DiseaseEric McDade, Haiyan Liu, Quoc Bui, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|September 23, 2025
The relationship of soluble tau species with Alzheimer's disease amyloid plaque removal and tau pathologyEric M McDade, Nicolas R Barthélemy, Guoqiao Wang, et al.
Acta Neuropathologica|June 3, 2025
Immunohistochemical evaluation of a trial of gantenerumab or solanezumab in dominantly inherited Alzheimer diseaseCharles D Chen, Erin E Franklin, Yan Li, et al.
Acta Neuropathologica|January 21, 2014
TMEM106B is a genetic modifier of frontotemporal lobar degeneration with C9orf72 hexanucleotide repeat expansionsMichael D Gallagher, Eunran Suh, Murray Grossman, et al.
Pageof 3